Related Experiment Videos
Development of an implantable small right ventricular assist device
M Yoshikawa1, K Nakata, T Takano
1Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
Summary
A new small implantable right ventricular assist device (RVAD), the Gyro PI pump, shows promise for treating right heart failure. This device demonstrated excellent performance and thrombus resistance in animal studies, supporting its use in biventricular assist systems.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Medical Devices
Background:
- Right ventricular failure affects 25-30% of patients needing ventricular assist devices.
- Currently, no small implantable right ventricular assist device (RVAD) is clinically available.
- Biventricular assist is crucial for patients with combined ventricular failure.
Purpose of the Study:
- To develop and evaluate a small, atraumatic, and antithrombogenic RVAD.
- To assess the feasibility and performance of the Gyro PI pump as a standalone RVAD and as part of a biventricular assist device (BiVAD) system.
Main Methods:
- Development of the Gyro PI pump, a small centrifugal blood pump with unique features to prevent thrombus formation (sealless design, secondary vanes, eccentric inlet).
- Inflow conduit designed with a biolized, thrombus-resistant tip.
- Biocompatibility and performance testing in calves, including long-term LVAD implantation and short-term RVAD feasibility studies.
Main Results:
- The Gyro PI pump demonstrated thrombus-free function as an LVAD for up to 284 days in calves.
- Short-term RVAD implantation in calves showed satisfactory operation without thromboembolic events.
- The pump maintained adequate blood flow and gas exchange, with no significant abnormalities in explanted organs.
Conclusions:
- The Gyro PI pump is suitable as a single implantable RVAD.
- The device is a feasible component for BiVAD systems, showing excellent pump performance and thrombus resistance.